Related Experiment Videos
Advanced prostatic carcinoma: flutamide therapy after conventional endocrine treatment
Urology
|August 11, 1975
Abstract:
Twenty-six patients with advanced prostatic carcinoma refractory to conventional endocrine treatment were treated with a new oral nonsteriodal antiandrogen, flutamide. There were 6 responders and 20 failures. No serious toxicity attributable to flutamide was observed.